Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2024-11-22
Product name
Alinity c Triglyceride R1
CAS No.
26628-22-8
1.2.1 Relevant identified uses
For In Vitro Diagnostic Use
Emergency telephone
(800) 424-9300
Icons in SDS
Company Information
company name
Abbott Diagnostics
GHS Information
Signal word
none
Section 2
SECTION 2: Hazards identification
(29 CFR 1910.1200) Classification of the substance or mixture
2.2 Label elements
The product is labelled according to the Globally Harmonized System (GHS)
Hazard pictograms
none
Signal word
none
Hazardous Ingredients
Sodium azide
Hazard statements
none
Precautionary statements
P501 Dispose of contents / container in accordance with local regulations.
Principle Routes of Exposure
- Skin: No adverse effects expected when used as directed. - Eye: No adverse effects expected when used as directed. - Inhalation: No adverse effects expected when used as directed. - Ingestion: No adverse effects expected when used as directed. · Health: No adverse effects expected if used as directed. Product name: Alinity c Triglyceride R1 · Fire: Noncombustible · Reactivity: Minimal hazard - Stable, even in a fire. Not reactive with water. Not an oxidizer.
2.1 Classification of the substance or mixture
The classification was made according to U.S. OSHA 29 CFR 1910.1200 and 1910.1030 and applicable European regulations, and is expanded upon from supplier company and/or literature data. This product has been evaluated per the classification criteria in the Globally Harmonized System of Classification and Labelling of Chemicals (GHS). This product does not meet the criteria for classification in accordance with the GHS. · Label elements · GHS label elements: The product is labelled according to the Globally Harmonized System (GHS). · Hazard pictograms: none · Signal word: none · Hazard-determining components of labeling: Sodium azide · Hazard statements: none · Precautionary statements: P501 Dispose of contents / container in accordance with local regulations. · Routes of Exposure: - Skin: No adverse effects expected when used as directed.